Fabrazyme 35 mg

Fabrazyme 35 mg is a medicine authorised by Swissmedic under authorisation number 56261. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 July 2003 and the authorisation is valid without a time limit. ATC code A16AB04 places the medicine in the group Other alimentary tract and metabolism products.

  • Dispensing category A
  • Authorisation number 56261
  • ATC A16AB04
  • Biotechnological medicines
Authorisation data
Authorisation number56261
NameFabrazyme 35 mg
Full nameFabrazyme 35 mg, poudre pour solution à diluer pour perfusion
Authorisation holderSanofi-Aventis (Suisse) SA
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeA16AB04
First authorisation25 July 2003
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Fabrazyme 35 mg, poudre pour solution à diluer pour perfusionA25 July 2003
3Fabrazyme 5 mg, poudre pour solution à diluer pour perfusionA01 September 2020

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
21Durchstechflasche(n)A16AB0407.14.0.A
31Durchstechflasche(n)A16AB0407.14.0.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Fabrazyme 35 mg authorised in Switzerland?

Yes. Fabrazyme 35 mg is authorised by Swissmedic under authorisation number 56261, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Fabrazyme 35 mg have?

Fabrazyme 35 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Fabrazyme 35 mg?

The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com